Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions

G. Ruffolo, A. Iyer, P. Cifelli, C. Roseti, A. Mühlebner, J. van Scheppingen, T. Scholl, JA. Hainfellner, M. Feucht, P. Krsek, J. Zamecnik, FE. Jansen, WG. Spliet, C. Limatola, E. Aronica, E. Palma,

. 2016 ; 95 (-) : 93-101. [pub] 20160716

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18011114

Tuberous sclerosis complex (TSC) is a rare multi-system genetic disease characterized by several neurological disorders, the most common of which is the refractory epilepsy caused by highly epileptogenic cortical lesions. Previous studies suggest an alteration of GABAergic and glutamatergic transmission in TSC brain indicating an unbalance of excitation/inhibition that can explain, at least in part, the high incidence of epilepsy in these patients. Here we investigate whether TSC cortical tissues could retain GABAA and AMPA receptors at early stages of human brain development thus contributing to the generation and recurrence of seizures. Given the limited availability of pediatric human brain specimens, we used the microtransplantation method of injecting Xenopus oocytes with membranes from TSC cortical tubers and control brain tissues. Moreover, qPCR was performed to investigate the expression of GABAA and AMPA receptor subunits (GABAA α1-5, β3, γ2, δ; GluA1, GluA2) and cation chloride co-transporters NKCC1 and KCC2. The evaluation of nine human cortical brain samples, from 15 gestation weeks to 15years old, showed a progressive shift towards more hyperpolarized GABAA reversal potential (EGABA). This shift was associated with a differential expression of the chloride cotransporters NKCC1 and KCC2. Furthermore, the GluA1/GluA2 mRNA ratio of expression paralleled the development process. On the contrary, in oocytes micro-transplanted with epileptic TSC tuber tissue from seven patients, neither the GABAA reversal potential nor the GluA1/GluA2 expression showed similar developmental changes. Our data indicate for the first time, that in the same cohort of TSC patients, the pattern of both GABAAR and GluA1/GluA2 functions retains features that are typical of an immature brain. These observations support the potential contribution of altered receptor function to the epileptic disorder of TSC and may suggest novel therapeutic approaches. Furthermore, our findings strengthen the novel hypothesis that other developmental brain diseases can share the same hallmarks of immaturity leading to intractable seizures.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011114
003      
CZ-PrNML
005      
20180416101615.0
007      
ta
008      
180404s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nbd.2016.07.014 $2 doi
035    __
$a (PubMed)27425893
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ruffolo, Gabriele $u Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, Rome, Italy.
245    10
$a Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions / $c G. Ruffolo, A. Iyer, P. Cifelli, C. Roseti, A. Mühlebner, J. van Scheppingen, T. Scholl, JA. Hainfellner, M. Feucht, P. Krsek, J. Zamecnik, FE. Jansen, WG. Spliet, C. Limatola, E. Aronica, E. Palma,
520    9_
$a Tuberous sclerosis complex (TSC) is a rare multi-system genetic disease characterized by several neurological disorders, the most common of which is the refractory epilepsy caused by highly epileptogenic cortical lesions. Previous studies suggest an alteration of GABAergic and glutamatergic transmission in TSC brain indicating an unbalance of excitation/inhibition that can explain, at least in part, the high incidence of epilepsy in these patients. Here we investigate whether TSC cortical tissues could retain GABAA and AMPA receptors at early stages of human brain development thus contributing to the generation and recurrence of seizures. Given the limited availability of pediatric human brain specimens, we used the microtransplantation method of injecting Xenopus oocytes with membranes from TSC cortical tubers and control brain tissues. Moreover, qPCR was performed to investigate the expression of GABAA and AMPA receptor subunits (GABAA α1-5, β3, γ2, δ; GluA1, GluA2) and cation chloride co-transporters NKCC1 and KCC2. The evaluation of nine human cortical brain samples, from 15 gestation weeks to 15years old, showed a progressive shift towards more hyperpolarized GABAA reversal potential (EGABA). This shift was associated with a differential expression of the chloride cotransporters NKCC1 and KCC2. Furthermore, the GluA1/GluA2 mRNA ratio of expression paralleled the development process. On the contrary, in oocytes micro-transplanted with epileptic TSC tuber tissue from seven patients, neither the GABAA reversal potential nor the GluA1/GluA2 expression showed similar developmental changes. Our data indicate for the first time, that in the same cohort of TSC patients, the pattern of both GABAAR and GluA1/GluA2 functions retains features that are typical of an immature brain. These observations support the potential contribution of altered receptor function to the epileptic disorder of TSC and may suggest novel therapeutic approaches. Furthermore, our findings strengthen the novel hypothesis that other developmental brain diseases can share the same hallmarks of immaturity leading to intractable seizures.
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x růst a vývoj $x metabolismus $x patologie $7 D001921
650    _2
$a nemoci mozku $x patologie $7 D001927
650    _2
$a dítě $7 D002648
650    _2
$a kohortové studie $7 D015331
650    _2
$a epilepsie $x etiologie $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a oocyty $7 D009865
650    _2
$a receptory GABA-A $x metabolismus $7 D011963
650    _2
$a záchvaty $x patofyziologie $7 D012640
650    _2
$a symportéry $x metabolismus $7 D027981
650    _2
$a tuberózní skleróza $x genetika $x patologie $x patofyziologie $7 D014402
650    _2
$a Xenopus $7 D014981
655    _2
$a časopisecké články $7 D016428
700    1_
$a Iyer, Anand $u Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands.
700    1_
$a Cifelli, Pierangelo $u Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, Rome, Italy; Ri.MED Foundation, Palermo, Italy.
700    1_
$a Roseti, Cristina $u IRCCS San Raffaele Pisana, Rome, Italy.
700    1_
$a Mühlebner, Angelika $u Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands; Department of Pediatrics, Medical University Vienna, Austria.
700    1_
$a van Scheppingen, Jackelien $u Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands.
700    1_
$a Scholl, Theresa $u Department of Pediatrics, Medical University Vienna, Austria.
700    1_
$a Hainfellner, Johannes A $u Institute of Neurology, Medical University Vienna, Austria.
700    1_
$a Feucht, Martha $u Department of Pediatrics, Medical University Vienna, Austria.
700    1_
$a Krsek, Pavel $u Department of Pediatric Neurology, Charles University, Second Medical School, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, Charles University, Second Medical School, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Jansen, Floor E $u Department of Pediatric Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands.
700    1_
$a Spliet, Wim G M $u Department of Pathology, University Medical Center Utrecht, The Netherlands.
700    1_
$a Limatola, Cristina $u Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, Rome, Italy; IRCCS Neuromed, Isernia, Italy.
700    1_
$a Aronica, Eleonora $u Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN)-Epilepsy Institute in the Netherlands Foundation, Heemstede, The Netherland. Electronic address: e.aronica@amc.uva.nl.
700    1_
$a Palma, Eleonora $u Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, Rome, Italy; IRCCS San Raffaele Pisana, Rome, Italy. Electronic address: eleonora.palma@uniroma1.it.
773    0_
$w MED00008403 $t Neurobiology of disease $x 1095-953X $g Roč. 95, č. - (2016), s. 93-101
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27425893 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180416101712 $b ABA008
999    __
$a ok $b bmc $g 1288599 $s 1007926
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 95 $c - $d 93-101 $e 20160716 $i 1095-953X $m Neurobiology of disease $n Neurobiol Dis $x MED00008403
LZP    __
$a Pubmed-20180404
Back

Find record

Citation metrics

Archiving options